Trafficking of PLP/DM20 and cAMP signaling in immortalized jimpy oligodendrocytes

GLIA

Volumn 40, Issue 3, 2002, Pages 300-311

  Ghandour, M Said ^a,e   Feutz, Anne Catherine ^a   Jalabi, Walid ^a   Taleb, Omar ^b   Bessert, Denise ^c   Cypher, Maria ^d   Carlock, Leon ^d   Skoff, Robert P ^c  

^a CNRS   (France)

^b INSERM   (France)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Center for Molecular Medicine and Genetics   (United States)

^e UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

Jimpy mice; Myelin; Oligodendrocyte; Protein expression imaging; Proteolipid protein

Indexed keywords

ANIMALS; BUCLADESINE; CELL DIFFERENTIATION; CELL LINE, TRANSFORMED; CELL MEMBRANE; CYCLIC AMP; CYCLIC AMP RESPONSE ELEMENT MODULATOR; DEMYELINATING DISEASES; DISEASE MODELS, ANIMAL; DNA-BINDING PROTEINS; GREEN FLUORESCENT PROTEINS; LUMINESCENT PROTEINS; MEMBRANE POTENTIALS; MICE; MICE, JIMPY; MYELIN PROTEOLIPID PROTEIN; MYELIN SHEATH; NERVE TISSUE PROTEINS; OLIGODENDROGLIA; PROTEIN TRANSPORT; RECOMBINANT FUSION PROTEINS; REPRESSOR PROTEINS; RNA, MESSENGER; SIGNAL TRANSDUCTION;

EID: 0036918299     PISSN: 08941491     EISSN: None     Source Type: Journal    
DOI: 10.1002/glia.10122     Document Type: Article

References (48)

1. Attali B, Wang N, Kolot A, Sobko A, Cherepanov V, Soliven B. 1997. Characterization of delayed rectifier Kv channels in oligodendrocytes and progenitor cells. J Neurosci 17:8234-8245.
2. Bauer J, Bradl M, Klein M, Leisser M, Deckwerth TL, Wekerle H, Lassmann H. 2002. Endoplasmic reticulum stress in PLP-overexpressing transgenic rats: Gray matter oligodendrocytes are more vulnerable than white matter oligodendrocytes. J Neuropathol Exp Neurol 61:12-22.
3. Benjamins JA, Studzinski DM, Skoff RP, Nedelkoska L, Carrey EA, Dyer CA. 1989. Recovery of proteolipid protein in mice heterozygous for the jimpy gene. J Neurochem 53:279-286.
4. Bradl M, Bauer J, Inomata T, Zielasek J, Nave KA, Toyka K, Lassmann H, Wekerle H. 1999. Transgenic Lewis rats overexpressing the proteolipid protein gene: Myelin degeneration and its effect on T cell-mediated experimental autoimmune encephalomyelitis. Acta Neuropathol 97:595-606.
5. Campagnoni AT, Skoff RP. 2001. The pathobiology of myelin mutants reveal novel biological functions of the MBP and PLP genes. Brain Pathol 11:74-91.
6. Casaccia-Bonnefil P. 2000. Cell death in the oligodendrocyte lineage: A molecular perspective of life/death decisions in development and disease. Glia 15:124-135.
7. Duncan ID, Hammang JP, Goda S, Quarles RH. 1989. Myelination in the jimpy mouse in the absence of proteolipid protein. Glia 2:148-154.
8. Feutz AC, Bellomi I, Allinquant B, Schladenhaufen Y, Ghandour MS. 1995. Isolation and characterization of defective jimpy oligodendrocytes in culture. J Neurocytol 24:865-877.
9. Feutz AC, Pham-Dinh D, Alliquant B, Miehe M, Ghandour MS. 2001. An immortalized jimpy oligodendrocyte cell line: Defects in cell cycle and cAMP pathway. Glia 34:241-252.
10. Folco EJ, Koren G. 1997. Degradation of the inducible cAMP early repressor (ICER) by the ubiquitin-proteasome pathway. Biochem J 328:37-43.
11. Ghandour MS, Skoff RP. 1988. Expression of galactocerebroside in developing normal and jimpy oligodendrocytes in situ. J Neurocytol 17:485-498.
12. Gow A, Friedrich VL Jr, Lazzarini RA. 1994. Many naturally occurring mutations of myelin proteolipid protein impair its intracellular transport. J Neurosci Res 37:574-583.
13. Gow A, Southwood CM, Lazzarini RA. 1998. Disrupted proteolipid protein trafficking results in oligodendrocyte apoptosis in an animal model of Pelizaeus-Merzbacher disease. J Cell Biol 140:925-934.
14. Hamill OP, Marty A, Neher E, Sakmann B, Sigworth FJ. 1981. Improved patch-clamp techniques for high resolution current recording from cells and cell-free membrane patches. Pflügers Arch 391:85-100.
15. Helynck G, Luu B, Nussbaum JL, Picken D, Skalidis G, Trifilieff E, Van Dorsselaer A, Seta P, Sandeaux R, Gavach D, Heitz F, Simon D, Spach G, 1983. Brain proteolipids. Isolation, purification and effect on ionic permeability of membranes. Eur J Biochem 133:689-695.
16. Hertz L, Chaban G, Hertz E. 1980. Abnormal metabolic response to excess potassium in astrocytes from the jimpy mouse, a convulsing neurological mutant. Brain Res 181:482-487.
17. Ikenaka K, Kagawa T. 1995. Transgenic systems in studying myelin gene expression. Dev Neurosci 17:127-136.
18. Jung M, Sommer I, Schachner M, Nave KA. 1996. Monoclonal antibody O10 defines a conformationally sensitive cell-surface epitope of proteolipid protein (PLP): Evidence that PLP misfolding underlies dysmyelination in mutant mice. J Neurosci 16:7920-7929.
19. Kagawa T, Ikenaka K, Inoue Y, Kuriyama S, Tsujii T, Nakao J, Nakajima K, Aruga J, Okano H, Mikoshiba K. 1994. Glial cell degeneration and hypomyelination caused by overexpression of myelin proteolipid protein gene. Neuron 13:427-442.
20. Kim Y, Pfeiffer SE. 1999. Myelin glycosphingolipid/cholesterol-enriched microdomains selectively sequester the non-compact myelin proteins CNP and MOG. J Neurocytol 28:281-293.
21. Knapp PE, Skoff RP. 1993. Jimpy mutation affects astrocytes: Lengthening of the cell cycle in vitro. Dev Neurosci 15:31-36.
22. Knapp PE. 1996. Proteolipid protein: Is it more than just a structural component of myelin? Dev Neurosci 18:297-308.
23. Knapp PE, Maderspach K, Hauser KF. 1998. Endogenous opioid system in developing normal and jimpy oligodendrocytes mu and kappa opioid receptors mediate differential mitogenic and growth responses. Glia 22:189-201.
24. Knapp PE, Ismaili S, Hauser KF, Ghandour MS. 1999. Abnormal Ca(2+) regulation in oligodendrocytes from the dysmyelinating jimpy mouse. Brain Res 847:332-337.
25. Knutson P, Ghiani CA, Zhou JM, Gallo V, McBain CJ. 1997. K+ channel expression and cell proliferation are regulated by intracellular sodium and membrane depolarization in oligodendrocyte progenitor cells. J Neurosci 17:2669-2682.
26. Krämer EM, Schardt A, Nave KA. 2001. Membrane traffic in myelinating oligodendrocytes. Microsc Res Tech 52:656-671.
27. Krueger DA, Mao D, Warner EA, Dowd DR. 1999. Functional analysis of the mouse ICER (inducible cAMP early repressor) promoter: Evidence for a protein that blocks calcium responsiveness of the CAREs (cAMP autoregulatory elements). Mol Endocrinol 13:1207-1217.
28. Lees MB. 1998. A history of proteolipids: A personel memoir. Neurochem Res 23:261-271.
29. Le Goascogne C, Eychenne B, Tonon MC, Lachapelle F, Baumann N, Robel P. 2000. Neurosteroid progesterone is up-regulated in the brain of jimpy and shiverer mice. Glia 29:14-24.
30. Macklin WB, Gardinier MV, King KD, Kampf K. 1987. An AG to GG transition at a splice site in the myelin proteolipid protein gene in jimpy mice results in the removal of an exon. FEBS Lett 223:417-421.
31. McMorris FA. 1983. Cyclic AMP induction of the myelin enzyme 2′,3′-cyclic nucleotide 3′-phosphohydrolase in rat oligodendrocytes. J Neurochem 41:506-515.
32. Molina CA, Foulkes NS, Lalli E, Sassone-corsi P. 1993. Inducibility and negative autoregulation of CREM: An alternative promoter directs the expression of ICER, an early response repressor. Cell 75:875-886.
33. Nadon NL, Amheiter H, Hudson LD. 1994. A combination of PLP and DM20 transgene promotes partial myelination in the jimpy mouse. J Neurochem 63:822-833.
34. Nadon NL, West M. 1998. Myelin proteolipid protein: Function in myelin structure is distinct from its role in oligodendrocyte development. Dev Neurosci 20:533-539.
35. Nave KA, Lai C, Bloom FE, Milner RJ. 1986. Jimpy mutant mouse: A 74-base deletion in the mRNA for myelin proteolipid protein and evidence for a primary defect in RNA splicing. Proc Natl Acad Sci USA 83:9264-9268.
36. Raible DW, McMorris FA. 1989. Cyclic AMP regulates the rate of differentiation of oligodendrocytes without changing the lineage commitment of their progenitors. Dev Biol 133:437-446.
37. Readhead C, Schneider A, Griffiths I, Nave KA. 1994. Premature arrest of myelin formation in transgenic mice with increased proteolipid protein gene dosage. Neuron 3:583-595.
38. Roussel G, Neskovic NM, Trifilieff E, Artault JC, Nussbaum JL. 1987. Arrest of proteolipid transport through the Golgi apparatus in jimpy brain. J Neurocytol 16:195-204.
39. Sato-Bigbee C, DeVries GH. 1996. Treatment of oligodendrocytes with antisense deoxyoligonucleotide directed against CREB mRNA: Effect on the cyclic AMP-dependent induction of myelin basic protein expression. J Neurosci Res 4:98-107.
40. Schneider AM, Griffiths IR, Readhead C, Nave KA. 1995. Dominant-negative action of the jimpy mutation in mice complemented with an autosomal transgene for myelin proteolipid protein. Proc Natl Acad Sci USA 92:4447-4451.
41. Schwob VS, Clark HB, Agrawal D, Agrawal HC. 1985. Electron microscopic immunocytochemical localization of myelin proteolipid protein and myelin basic protein to oligodendrocytes in rat brain during myelination. J Neurochem 45:559-571.
42. Simons M, Kramer EM, Thiele C, Stoffel W, Trotter J. 2000. Assembly of myelin by association of proteolipid protein with cholesterol- and galactosylceramide-rich membrane domains. J Cell Biol 151:143-154.
43. Skoff RP. 1976. Myelin deficit in the jimpy mouse may be due to cellular abnormalities in astroglia. Nature 264:560-562.
44. Skoff RP, Knapp PE. 1992. Phenotypic expression of X-linked genetic defects affecting myelination. In: Materson RE, editor. Myelin Biology and Chemistry. Boca Raton, FL: CRC Press. p 653-676.
45. Southwood C, Gow A. 2001. Molecular pathways of oligodendrocyte apoptosis revealed by mutations in the proteolipid protein gene. Microsc Res Tech 52:700-708.
46. Thomson CE, Montague P, Jung M, Nave KA, Griffiths IR. 1997. Phenotypic severity of murine PLP mutants reflects in vivo and in vitro variations in transport of PLP isoproteins. Glia 20:322-332.
47. Trifilieff E, Luu B, Nussbaum JL, Roussel G, Espinosa de Los Monteros A, Sabatier J, Van Rietschoten JA. 1986. A specific immunological probe for the major myelin proteolipid: Confirmation of a deletion in DM-20. FEBS Lett 198:235-239.
48. Yamada M, Ivanova A, Yamaguchi Y, Lees MB, Ikenaka K. 1999. Proteolipid protein gene products can be secreted and exhibit biological activity during early development. J Neurosci 19:2143-2151.